This blog is related to the various litigations related to patents w.r.t pharma industry.
Wednesday, April 15, 2009
AstraZeneca to market Crestor in India
AstraZeneca India has introduced Crestor (rosuvastatin) as 5, 10, 20 and 40 mg tablets. The drug is indicated for use in the treatment of dyslipidemia, atherosclerosis and primary hypercholesterolaemia.
No comments:
Post a Comment